HYPAQUE-M,90%
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Nov 1955
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYPAQUE-M, 90% is an injectable diagnostic contrast agent developed by GE HealthCare and approved in 1955. It is used in radiographic imaging procedures to enhance visualization of internal structures. The product represents a legacy diagnostic imaging technology with established clinical utility.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%) indicates smaller, defensive commercial team focused on market retention rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
HYPAQUE-M, 90% generates 845 linked job opportunities across GE HealthCare, with heavy emphasis on engineering, finance, and manufacturing roles reflecting the product's mature operational needs and cost-focused strategy. Career progression on this product emphasizes operational excellence, supply chain management, and financial optimization rather than commercial expansion or innovation.
Software Engineer
Worked on HYPAQUE-M,90% at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.